5 Amino 1 MQ Capsules

Buy 5-Amino-1MQ Online

5-Amino-1MQ, also known as 5A1MQ, is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT). It has attracted significant research interest for its potential effects on metabolism, body composition, glucose regulation, and fatty liver disease.

Product Information

Preclinical studies have found that NNMT inhibition with 5A1MQ can influence body weight, fat accumulation, glucose tolerance, insulin sensitivity, and liver metabolism in diet-induced obese mice. These findings remain preclinical and should not be presented as established human outcomes.

How It Works

5-Amino-1MQ inhibits NNMT, an enzyme involved in nicotinamide and methyl-group metabolism. Reducing NNMT activity can alter cellular metabolic pathways associated with energy balance and metabolic function.

POTENTIAL BENEFITS

1. Supports Metabolic Research

5-Amino-1MQ has demonstrated broad metabolic effects in animal models, making NNMT inhibition an increasingly interesting strategy for investigating obesity and metabolic dysfunction.

2. Body Composition Research

In diet-induced obese mice, 5A1MQ reduced gains in body weight and fat mass in a dose-dependent manner. This has positioned NNMT inhibition as a potential target for body-composition research.

3. Glucose and Insulin Sensitivity

Animal studies reported improvements in oral glucose tolerance and insulin sensitivity following 5A1MQ administration, providing a strong rationale for continued metabolic research.

4. Liver Metabolism

5A1MQ treatment in obese mice was associated with reduced hepatic steatosis, liver triglycerides, and macrophage infiltration. These findings suggest potential relevance to metabolic liver research.

Dosage

There is currently no established human therapeutic dosage for 5-Amino-1MQ. Published dosing research includes animal pharmacokinetic and efficacy studies, but these doses cannot be directly converted into a validated human regimen.

Side Effects

Human safety data remain limited because the compound is primarily supported by preclinical research. Potential metabolic, hepatic, cardiovascular, or drug-interaction risks therefore remain incompletely characterized.

References

1. PubMed - 5-Amino-1MQ and NNMT inhibition PubMed

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

Please click here to access instructions on how to make a payment.

How to Pay